Form 4 for BHVN Biohaven Ltd.
Accepted 2022-10-26 00:00:00 ET · period of report 2022-10-25 · accession 0001562180-22-007333 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-26 | 2022-10-25 | BHVN | Buten Matthew | CFO | P - Purchase | $10.50 | +142.9K | 166.7K | +600% | +$1.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-10-25 | P | A | 142,857 | $10.50 | 166,653 | D | — | — | (F1) Represents common shares acquired in an underwritten public offering. |